The Diabetes Virtual Press Office was developed by GlaxoSmithKline as a resource for medical and business news media. GlaxoSmithKline cannot accept responsibility for the way in which information from this website is used and the content of this website should not be relied upon as the basis for any decision, action or omission.     This website is not intended for use by consumer media, patients, healthcare professionals or the general public nor is this site intended for use by US residents and/or journalists.               Legal Notices   Privacy Policy